NeonMind Announces Cancellation of Securities
NeonMind Signs Agreement to complete Reverse Merger with Lancaster Lithium Inc.
NeonMind Announces Management Change
Sign up today and receive company updates straight to your inbox.
NeonMind is an integrated psychedelic drug development and wellness company focused on therapeutic uses of psychedelics to address public health needs including obesity, weight management and mental health. NeonMind has two operating divisions, a pharmaceutical division engaged in drug development research for the potential therapeutic uses of psychedelic compounds, and a medical services division focused on launching specialty mental health clinics that integrate psychedelic therapeutics into traditional psychotherapy settings.
Investor Contact Information
NeonMind Biosciences Inc.
5 – 519 Dundas St. W.
Oakville, ON L6M 5K3
T: +1 (705) 710-NEON /
+1 (705) 710-6366
Endeavor Trust Corporation